Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
Canada
Vancouver Cancer Center, Vancouver, British Columbia Juravinski Cancer Center, Hamilton, Ontario London Health Science Centre - Victoria Hospital, London, Ontario Ottawa Hospital, Ottawa, Ontario Last updated November 2025